Home
About
Company
History
Careers
Contact
Pipeline
Portfolio
BaroFeron
Candidates
Technology
PreEMT
New Biologics
Quality
Increase Throughput
High Pressure Refolding
Alliances
Partnerships
Licensing Opportunities
News
Press Releases
Publications
Events
Contacts
Press Releases
Publications
Events
Contacts
BaroFold Inc., Initiates First Human Studies for Multiple Sclerosis Drug Candidate, BaroFeron™
06/16/2008
© BaroFold, Inc. 2012